ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,350,035 | -23.6% | 719,014 | -2.0% | 0.00% | – |
Q2 2023 | $5,692,829 | +807.3% | 733,612 | +566.4% | 0.00% | – |
Q1 2023 | $627,456 | -51.6% | 110,080 | -50.0% | 0.00% | – |
Q4 2022 | $1,296,742 | +268.4% | 220,160 | +100.0% | 0.00% | – |
Q3 2022 | $352,000 | -28.6% | 110,080 | 0.0% | 0.00% | – |
Q2 2022 | $493,000 | -84.4% | 110,080 | -81.5% | 0.00% | – |
Q1 2022 | $3,170,000 | -83.0% | 593,549 | -53.3% | 0.00% | -100.0% |
Q4 2021 | $18,696,000 | -15.6% | 1,271,828 | +20.0% | 0.00% | 0.0% |
Q3 2021 | $22,162,000 | +0.1% | 1,059,899 | -15.3% | 0.00% | 0.0% |
Q2 2021 | $22,146,000 | -33.8% | 1,251,913 | -8.3% | 0.00% | -50.0% |
Q1 2021 | $33,456,000 | +175.3% | 1,365,565 | +280.3% | 0.00% | +100.0% |
Q4 2020 | $12,154,000 | +303.9% | 359,043 | +198.4% | 0.00% | – |
Q3 2020 | $3,009,000 | -9.0% | 120,320 | +22.8% | 0.00% | – |
Q2 2020 | $3,305,000 | – | 97,991 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |